4.7 Article

How Vaccinations Changed the Outcome of COVID-19 Infections in Kidney Transplant Patients: Single-Center Experience

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients

Giuseppe S. Netti et al.

Summary: mTOR inhibitors (mTOR-I) treatment is associated with a better immune response to COVID-19 vaccine in kidney transplant recipients (KTR), not only by increasing vaccine-induced antibodies but also by stimulating anti-SARS-CoV-2 T cell response.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Letter Medicine, General & Internal

Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series

Sophie Caillard et al.

ANNALS OF INTERNAL MEDICINE (2022)

Letter Hematology

COVID-19 vaccine hesitancy in renal transplant recipients

Nikolina Basic-Jukic et al.

THERAPEUTIC APHERESIS AND DIALYSIS (2022)

Article Biotechnology & Applied Microbiology

Estimating the size of anti-vax and vaccine hesitant populations in the US, UK, and Canada: comparative latent class modeling of vaccine attitudes

Timothy B. Gravelle et al.

Summary: Vaccine hesitancy poses a significant obstacle to global vaccination efforts, and latent class analysis reveals the variations in vaccine attitudes across countries and demographic subgroups.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Letter Medicine, General & Internal

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Microbiology

COVID-19 Infection in Kidney Transplant Patients: An Italian One Year Single Centre Experience

Mariarosaria Campise et al.

Summary: Elderly and comorbid kidney transplant patients with COVID-19 are at high risk for severe symptoms, with acute kidney injury and age being the most important factors influencing mortality. Adjustments in steroid dosage and calcineurin inhibitors play a significant role in treatment outcomes.

PATHOGENS (2021)